Etropal AD
BBSEBG:ETR2.62
EUR
-0.04
(-1.50%)
ISIN
BG1100001038
Return %
Stock
S&P 500
1Y
28.11
14.20
3Y
-1.46
81.12
5Y
-9.30
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Plamen Peev Patev
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Etropole Bulgaria
- IPO Date
- Nov 7, 2007
- Website
- etropal.eu
- Similar Companies
- Business
- Etropal AD is a Bulgaria-based medical device manufacturer that specializes in the design, production, and commercialization of sterile, single-use medical consumables and specialized healthcare equipment. Founded in 1977 and headquartered in Etropole, Bulgaria, the company operates across domestic and international healthcare markets, serving public hospital networks, private clinical care providers, specialized dialysis centers, and pharmaceutical distributors. The company structures its core product and service portfolio into several primary business segments: hemodialysis consumables, including synthetic hollow-fiber dialyzers, arterial and venous bloodline tubing sets, arteriovenous (AV) fistula needles, bicarbonate cartridges, and liquid dialysis concentrates; infusion and transfusion therapy supplies, comprising standard gravity infusion sets, blood transfusion administration systems, extension lines, multidirectional stopcocks, intravenous cannulas, and single-use hypodermic syringes and needles; general medical and urological disposables, featuring foley and nelaton urinary catheters, suction tubes, surgical drainage systems, oxygen masks, and nasal cannulas; and specialized contract manufacturing services, encompassing cleanroom plastic injection molding, automated device assembly, custom blister packaging, and industrial ethylene oxide (EtO) sterilization services for third-party healthcare brands. Etropal AD distributes its products throughout Bulgaria and exports to healthcare markets across Central and Eastern Europe, the Middle East, and North Africa. In recent operational developments, the company has executed capital investment programs to modernize its Etropole production facilities, incorporating high-precision automated extrusion and assembly lines to enhance manufacturing efficiency and expand bloodline output capacity. Additionally, the company has advanced the transition of its medical device portfolio toward compliance with European Union Medical Device Regulation (EU MDR) standards, expanded its third-party contract manufacturing and OEM partnerships, and implemented supply chain optimization measures to strengthen its regional export footprint.